- No public price.
- Attested
- Type II
- —
- 2019
- US


Element5
by Element5 · founded 2019 · US
Agentic revenue-cycle and admin automation for home health, hospice and SNF post-acute providers.
On this page
Not rated: too little independent evidence yet.
- Regulatory & Compliance10/10
HIPAA + (SOC2 or BAA) attested
- Clinical Integration0/31.4
No EHR integrations listed
- Evidence Strength0/10
No peer-reviewed coverage
- Vendor & Market7.2/18
Founded 2019 (7 years)
- Sentiment & Transparency3.3/6.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- HIPAA / SOC2 / BAA10/10
HIPAA + (SOC2 or BAA) attested
- EHR integrations (count)0/18
No EHR integrations listed
- Top-3 EHR coverage (Epic / Oracle / Athena)0/8
None of the top-3 EHRs covered
- Bidirectional write-back0/5
No bidirectional write-back documented
- Peer-reviewed papers0/7
No peer-reviewed coverage
- RCT / meta-analysis / systematic review0/3
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market4/6
Founded 2019 (7 years)
- Pricing transparency3/7
Pricing on request, no public amounts
Agentic revenue-cycle and admin automation for home health, hospice and SNF post-acute providers.
No public price. HIPAA + SOC 2 Type II attested.
Evidence record
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Element5 record, https://medaiverdict.com/tools/element5, version November 2, 2026
Bottom line
Element5, founded in 2019 and based in San Jose, sells automation of eligibility, authorization, revenue cycle and regulatory submissions to home health, hospice and skilled nursing operators. Its latest sourced funding is a $30M Series B in 2022, and its homepage names Amedisys and Compassus among customers. No price is published. The homepage addresses post-acute operators, which leaves physician practices and hospitals outside its stated audience.
Is the agentic label new?
The 2021 Series A release described the product as artificial intelligence plus robotic process automation. The current site calls it an "Agentic Platform" and offers three engagement models: Ready to go Agents, Collaborative Design and Custom Agents. How much of the agentic layer is language-model based is not stated. A prior authorization agent called Neos has a page on the site that now sits at an archived address, and the reason is not given.
The vendor describes autonomous workflows making "rules-based decisions without human intervention", with exceptions routed to a web app for human review and a full audit trail. Regulatory work includes OASIS, HOPE and iQIES submissions.
Who funded Element5 and who runs it?
Insight Partners led both disclosed rounds. The Series A was $15M in August 2021. The Series B was $30M on May 3, 2022 and brought the total raised to $48.5M, according to Home Care magazine, which is also the 2022 article reporting an APAC headquarters in Chennai, India. The about page lists Joe Randesi as CEO, Eric Gordon as CRO, Bhavani Raman as COO and Murali Vivekanandan as CTO.
Which customers and numbers does the vendor cite?
The homepage names GHG, Amedisys, Compassus, AngMar Medical, VNA Health Group, VIA Health Partners and Vivie, with no customer count. It cites "727 automated workflows", "49 connected systems", "121K transactions per day" and "82%+ labor burden reduction". Customer stories claim a 50% time reduction on pre-claim review submissions and a 99% OASIS submission rate. All are the vendor's figures.
Which systems does it name?
The homepage says the platform connects to "EHRs, portals, and proprietary internal systems" and names no EHR. The platform page draws a bridge between EHR, payers, convenors and clearinghouses without names. Release titles in vendor news name WellSky (September 2023), AlayaCare (May 2022), KanTime and Homecare Homebase (a September 2025 alliance) as partners.
What does the compliance claim say?
The homepage says "SOC 2 Type II and HIPAA compliant" and shows AICPA SOC and HIPAA Verified badges.
How does a buyer engage?
Through the three engagement models and a contact form. No pricing page exists.
The verdict
Element5 has two disclosed rounds, named customers and a 2019 start, which is more history than the 2026 seed round at Claim Health, a vendor aimed at the same agencies. The unanswered point is which of the named partners are connected in production today.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
What deploys cleanly
Carries SOC 2 Type II, HIPAA per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
Who builds it
Element5 (Element5) was founded in 2019 in US, putting it 7 years into market.


